And I think the number of shorts is mind boggling
not so sure you are reading the chart correctly & objectively
We need a definitive close at 16+ to get this nanny to run
If I remember correctly, CLDX was up even more than this after the BMY news, then gave most of it back. Never safe to call any of these moves "decisive".
....following the IBB break-out.
Sentiment: Strong Buy
16 is on the way. This will give me something to watch while I'll wait for the profit taking in MNKD to be completed for the day and continue it's run up into the July 15th FDA date.
Getting The Go Ahead To File An NDA For Eteplirsen By The End of 2014
Eteplirsen was developed by Serepta dot celldex. I'm confused . Help me out.!
Shorts still short or shorts covering?
Celldex noted that data from solid tumor expansion cohorts in ... and preparing to submit our initial New Drug Application (NDA).